Premarket gainers lift HUM, CLOV, FSLY, ATEX, TEVA on upgrades, FDA OK
flags multiple premarket positive movers: HUM +17% after Baird upgrades; CLOV +10.5% on CMS Star rating action; FSLY +7% and AMT +7% after upgrades tied to Starling Spectrum; ATEX +5.5%, CCI +8%, and SPX-related tower-operator positives following Starling Spectrum; LITE +6% on CEO comments; DNA +5.25% for autonomous lab access for NSF X-Labs researchers; TEVA +4% on FDA approval of WELTRUZA.
HUM rose +17% after CMS released Star ratings and Baird upgraded the stock to OUTPERFORM. 5% on CMS Star ratings. CCI was up +8% following the Starling Spectrum win and positive action on tower operators. FSLY rose +7% after an upgrade to OUTPERFORM at Opp.
AMT added +7% following the Starling Spectrum win and positive action on tower operators. LITE climbed +6% on positive CEO comments. 5% following the Starling Spectrum win and positive action on tower operators. 25% after agreeing to provide autonomous lab access to NSF X-Labs researchers.
BULL was up +5% after Scotia upgraded the stock to OUTPERFORM. TEVA rose +4% after FDA approval of WELTRUZA. 25% following the Starling Spectrum win.